AI Article Synopsis

  • Dystrophinopathy, specifically Duchenne muscular dystrophy (DMD), is characterized by a lack of dystrophin in skeletal muscles, leading to muscle weakness, necrosis, inflammation, and fibrosis.
  • A unique case of a 10-year-old with asymptomatic dystrophinopathy was studied to understand the absence of muscle weakness, revealing differences in gene expression, particularly low levels of cathepsin K (CTSK).
  • The research suggests that higher CTSK expression in typical DMD patients contributes to muscle damage, while the lower levels in the asymptomatic patient may explain the lack of weakness, providing potential therapeutic insights for DMD.

Article Abstract

Dystrophinopathy is caused by alterations in the dystrophin gene. The severe phenotype, Duchenne muscular dystrophy (DMD), is caused by a lack of dystrophin in skeletal muscles, resulting in necrosis and regenerating fibers, inflammatory cells, and muscle fibrosis. Progressive muscle weakness is a characteristic finding of this condition. Here, we encountered a rare case of a 10-year-old patient with asymptomatic dystrophinopathy with no dystrophin expression and investigated the reason for the absence of muscle weakness to obtain therapeutic insights for DMD. Using RNA-seq analysis, gene expression in skeletal muscles was compared among patients with asymptomatic dystrophinopathy, three patients with typical DMD, and two patients without dystrophinopathy who were leading normal daily lives. Cathepsin K (CTSK), myosin heavy chain 3 (MYH3), and nodal modulator 3-like genes exhibited a >8-fold change, whereas crystallin mu gene (CRYM) showed a <1/8-fold change in patients with typical DMD compared with their expression in the patient with asymptomatic dystrophinopathy. Additionally, CTSK and MYH3 expression exhibited a >16-fold change (P < 0.01), whereas CRYM expression showed a <1/16-fold change (P < 0.01) in patients with typical DMD compared with their expression in those without dystrophinopathy. CTSK plays an essential role in skeletal muscle loss, fibrosis, and inflammation in response to muscles injected with cardiotoxin, one of the most common reagents that induce muscle injury. Increased CTSK expression is associated with muscle injury or necrosis in patients with DMD. The lack of muscle weakness in the patient with asymptomatic dystrophinopathy might be attributed to the low CTSK expression in the muscles. To the best of our knowledge, this is the first report to demonstrate that CTSK expression was significantly higher in the skeletal muscles of patients with DMD with a typical phenotype than in those without dystrophinopathy.

Download full-text PDF

Source
http://dx.doi.org/10.1111/neup.12995DOI Listing

Publication Analysis

Top Keywords

gene expression
8
duchenne muscular
8
muscular dystrophy
8
skeletal muscles
8
muscle weakness
8
asymptomatic dystrophinopathy
8
increase cathepsin
4
gene
4
cathepsin gene
4
expression duchenne
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!